土耳其重症监护病房医院获得性血流感染的流行病学与28天死亡危险因素:一项前瞻性观察性队列研究
该研究基于EUROBACT II前瞻性观察性多中心队列,分析土耳其24个ICU中547例医院获得性血流感染患者。最常见的感染来源为血管内导管(33.3%)和下呼吸道(32.0%),分离病原体以革兰阴性菌为主(67.1%)。在单一革兰阴性菌感染中,SOFA评分、碳青霉烯耐药、既往心肌梗死、COVID-19入院诊断和未实现感染源控制与死亡相关,而临床药师可及性和感染源控制与生存相关。
要点
- 医院获得性血流感染最常见来源为血管内导管(33.3%)和下呼吸道(32.0%)。
- 分离病原体中革兰阴性菌占67.1%,不动杆菌属碳青霉烯耐药率达90.4%。
- 单一革兰阴性菌感染中,碳青霉烯耐药(aHR 2.46)和未实现感染源控制(aHR 2.02)与死亡相关。
核心结论
- 考虑到高抗菌药物耐药率、感染源控制的重要性以及临床药师的可及性,土耳其ICU应采用多方面的管理方案。
研究设计与样本
- EUROBACT II为前瞻性观察性多大陆队列研究,本研究对其中的土耳其24个ICU患者进行亚组分析。
- 共纳入547例医院获得性血流感染患者,采用多变量Cox脆弱模型识别死亡危险因素。
主要发现
- 547例患者中58.7%为男性,中位年龄68岁(IQR 55-78)。
- 分离病原体共599株,革兰阴性菌占67.1%,革兰阳性菌占21.5%,真菌占11.2%。
- 碳青霉烯耐药在不动作菌属中占90.4%,在克雷伯菌属中占53.1%,在假单胞菌属中占48.8%。
- 单一革兰阴性菌血流感染(n=329)中,SOFA评分(aHR 1.20,95% CI 1.14-1.27)、碳青霉烯耐药(aHR 2.46,95% CI 1.58-3.84)、既往心肌梗死(aHR 1.86,95% CI 1.12-3.08)、COVID-19入院诊断(aHR 2.95,95% CI 1.25-6.95)和未实现感染源控制(aHR 2.02,95% CI 1.15-3.54)与死亡相关。
- 单一革兰阴性菌血流感染中,临床药师可及性(aHR 0.23,95% CI 0.06-0.90)和感染源控制(aHR 0.46,95% CI 0.28-0.77)与生存相关。
临床怎么用
- 作者认为,考虑到高抗菌药物耐药率、感染源控制的重要性以及临床药师的可及性,土耳其ICU应采用多方面的管理方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To uncover clinical epidemiology, microbiological characteristics and outcome determinants of hospital-acquired bloodstream infections (HA-BSIs) in Turkish ICU patients. METHODS: The EUROBACT II was a prospective observational multicontinental cohort study. We performed a subanalysis of patients from 24 Turkish ICUs included in this study. Risk factors for mortality were identified using multivariable Cox frailty models. RESULTS: Of 547 patients, 58.7% were male with a median [IQR] age of 68 [55-78]. Most frequent sources of HA-BSIs were intravascular catheter [182, (33.3%)] and lower respiratory tract [175, (32.0%)]. Among isolated pathogens (n = 599), 67.1% were Gram-negative, 21.5% Gram-positive and 11.2% due to fungi. Carbapenem resistance was present in 90.4% of Acinetobacter spp., 53.1% of Klebsiella spp. and 48.8% of Pseudomonas spp. In monobacterial Gram-negative HA-BSIs (n = 329), SOFA score (aHR 1.20, 95% CI 1.14-1.27), carbapenem resistance (aHR 2.46, 95% CI 1.58-3.84), previous myocardial infarction (aHR 1.86, 95% CI 1.12-3.08), COVID-19 admission diagnosis (aHR 2.95, 95% CI 1.25-6.95) and not achieving source control (aHR 2.02, 95% CI 1.15-3.54) were associated with mortality. However, availability of clinical pharmacists (aHR 0.23, 95% CI 0.06-0.90) and source control (aHR 0.46, 95% CI 0.28-0.77) were associated with survival. In monobacterial Gram-positive HA-BSIs (n = 93), SOFA score (aHR 1.29, 95% CI 1.17-1.43) and age (aHR 1.05, 95% CI 1.03-1.08) were associated with mortality, whereas source control (aHR 0.41, 95% CI 0.20-0.87) was associated with survival. CONCLUSIONS: Considering high antimicrobial resistance rate, importance of source control and availability of clinical pharmacists, a multifaceted management programme should be adopted in Turkish ICUs.
引用
- Aslan AT, Tabah A, Köylü B, et al. Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study. J Antimicrob Chemother. 2023. PMID: 37264485. doi:10.1093/jac/dkad167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。